<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
PFE
Pfizer
$
()


  • GSK announces LATITUDE phase III interim trial demonstrates 'superior efficacy'

    Today - 06:13am
  • EC approves Pfizer's VELSIPITY in moderately to severely active UC

    2/19/2024 - 16:06pm
  • Pfizer call volume above normal and directionally bullish

    2/16/2024 - 15:05pm
  • Longboard Pharmaceuticals initiated with a Buy at Citi

    2/15/2024 - 16:10pm
  • Carrick announces first patient dosed in trial of samuraciclib, vepdegestrant

    2/14/2024 - 08:22am
  • Moderna RSV vaccine efficacy declining quicker than peers', says TD Cowen

    2/8/2024 - 14:51pm
  • Alibaba downgraded, Disney upgraded: Wall Street's top analyst calls

    2/8/2024 - 09:44am
  • Arvinas, Pfizer: FDA grants Fast Track designation for ARV-471

    2/6/2024 - 06:49am
  • Genmab, Pfizer: EMA validates for review MAA of tisotumab vedotin

    2/2/2024 - 06:46am
  • U.S. sends offers for drugs selected for price negotiations, NY Times says

    2/1/2024 - 06:16am
  • What You Missed On Wall Street On Tuesday

    1/30/2024 - 16:32pm
  • What You Missed On Wall Street This Morning

    1/30/2024 - 11:58am
  • Notable open interest changes for January 30th

    1/30/2024 - 08:55am
  • Pfizer sees FY24 revenue of $8B from Comirnaty/Paxlovid

    1/30/2024 - 06:49am
  • Pfizer reports Q4 adjusted EPS 10c, consensus (22c)

    1/30/2024 - 06:49am
dynamic_feed Breaking News